Showing results (161-170 of 305) with videos related to
Sort By:
Pageof 31
Endocrinology|July 1, 1988
The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptorJ C Morris, N S Jiang, M C Charlesworth, et al.Annals of Neurology|March 1, 1992
Mild senile dementia of the Alzheimer type. 4. Evaluation of interventionL Berg, J P Miller, J Baty, et al.Biochemical and Biophysical Research Communications|April 16, 1998
Inhibition of GPI phospholipase C from Trypanosoma brucei by fluoro-inositol dodecylphosphonatesJ C Morris, P S Lei, H X Zhai, et al.Neurology|June 1, 1996
CSF excitatory amino acids and severity of illness in Alzheimer's diseaseJ G Csernansky, M E Bardgett, Y I Sheline, et al.Neurology|January 1, 1996
Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XIIE Koss, S Edland, G Fillenbaum, et al.Radiology|April 1, 1991
Senile dementia and healthy aging: a longitudinal CT studyF J Wippold, M H Gado, J C Morris, et al.Journal of Hematotherapy & Stem Cell Research|January 19, 2002
All-trans retinoic acid facilitates oncoretrovirus-mediated transduction of hematopoietic repopulating stem cellsL E Purton, J C Morris, I D Bernstein, et al.Journal of the International Neuropsychological Society : JINS|March 2, 1999
Cognitive speed in nondemented Parkinson's diseaseM C Smith, W P Goldman, K W Janer, et al.The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptakeM R Castro, E R Bergert, J R Goellner, et al.Neurology|July 6, 2000
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study GroupP N Tariot, P R Solomon, J C Morris, et al.Pageof 31